<DOC>
	<DOCNO>NCT01701622</DOCNO>
	<brief_summary>Hyperuricemia ( high uric acid level ) correlate hypertension ( high blood pressure ) overall cardiovascular disease risk several study . The relationship even note independent metabolic syndrome kidney function . It repeatedly note hyperuricemia independent risk factor death high cardiovascular disease risk . A recent review conclude strong evidence hyperuricemia gout couple atherosclerosis cardiovascular event . Although correlation hypertension hyperuricemia know , one publish study evaluate lower uric acid would reduce blood pressure . The author conclude newly diagnose hypertensive adolescent , allopurinol decrease blood pressure . Despite , evaluation therapeutic approach study . The hypothesis study febuxostat , new xanthine oxidase inhibitor , blood pressure lower effect superior allopurinol patient diagnose gout .</brief_summary>
	<brief_title>The Blood Pressure Effects Febuxostat Patients Previously Treated With Allopurinol : A Pilot Study</brief_title>
	<detailed_description>Screening Recruitment - Identify recruit 20 participant University Mississippi Medical Center General Internal Medicine/Hypertension Family Medicine Clinics . - Participants must currently take allopurinol treatment gout stable dose allopurinol least 2 month . - Any antihypertensive medication must stable dos least 2 month . - The identified patient invite participate study . Provide Consent - IRB approve comprehension survey administer participant determination competency provide consent . - The `` Consent Participate Research '' information discuss participant consent acquire . - Materials take potential participant review consent provide later date . Data collection - After consent provide , study personnel evaluate blood pressure ( BP ) . - Participants undergo 24-hour Ambulatory Blood Pressure Monitor ( ABPM ) . The normal fee ABPM waive . - Participants discontinue allopurinol initiate febuxostat comparable dose . Febuxostat provide participant cost . - If receive &lt; 300 mg allopurinol daily , provide febuxostat 40 mg daily . - If receive &gt; 300 mg allopurinol daily , provide febuxostat 80 mg daily . - After least 4 week febuxostat , participant repeat 24-hour ABPM . The normal fee ABPM waive . - After completion febuxostat portion study , participant receive compensation $ 50 end study . Compensation provide complete entire study . Results - Data collection add participant 's permanent medical record . - Results individual participant discuss participant well primary care provider . - The decision remain febuxostat resume allopurinol lie primary care provider .</detailed_description>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Febuxostat</mesh_term>
	<criteria>Patients currently treat University Mississippi Medical Center General Internal Medicine/Hypertension Family Medicine Clinics . Have diagnosis gout . Taking allopurinol stable dose least 2 month . Less 18 year old . Severe renal impairment define CrCl &lt; 30 mL/min . Previous diagnosis severe hepatic impairment . Currently take azathioprine , mercaptopurine , theophylline . Pregnant , breastfeeding , anticipate pregnancy breastfeeding . Arm circumference great 50 cm . Change antihypertensive medication within previous 2 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Blood Pressure</keyword>
	<keyword>Gout</keyword>
	<keyword>allopurinol</keyword>
	<keyword>febuxostat</keyword>
	<keyword>uric acid</keyword>
</DOC>